Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Open in API
Filings indexed 230 across all filing types
Latest filing 2025-08-18 Share Issue/Capital Cha…
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
DMS GROUP : AN INTERNATIONAL ALLIANCE FOR EUROPEAN TECHNOLOGICAL SOVEREIGNTY IN MEDICAL IMAGING - CAPITAL INCREASE OF A TOTAL AMOUNT OF EUR 6.9 MILLION RESERVED FOR INNOLUX, INNOCARE, BPIFRANCE AND NE
Share Issue/Capital Change Classification · 100% confidence The document is a press release detailing a capital increase of €6.9 million through the issuance of new shares to specific institutional investors (InnoLux, InnoCare, Bpifrance, and NextStage AM). It provides the legal framework, the number of shares issued, the subscription price, and the impact on capital structure. This falls under the category of share issuance and capital changes.
2025-08-18 English
DMS GROUP : NOUVELLE HAUSSE DU CHIFFRE D'AFFAIRES +3 % AU 1ER SEMESTRE 2025
Earnings Release Classification · 100% confidence The document is titled "COMMUNIQUÉ DE PRESSE • DMS Group Chiffre d'affaires du 1er semestre 2025" and contains key financial highlights (revenue figures, growth percentages) for the first half of 2025. It explicitly states the revenue figures and discusses business performance, significant events (Ukraine contract, FDA approval), and future outlook. This format, focusing on preliminary or key results for a specific period (H1 2025) released via a press release, aligns perfectly with the definition of an Earnings Release (ER). Although it contains some elements that might appear in an Interim Report (IR), the presentation style—a concise press release format announcing results rather than a comprehensive statutory report—points strongly to ER. The document is not a full statutory report (10-K or IR) but an initial announcement of results. H1 2025
2025-07-21 French
DMS GROUP: FURTHER INCREASE IN REVENUE +3% IN H1 2025
Earnings Release Classification · 100% confidence The document is titled "FURTHER INCREASE IN REVENUE +3% IN H1 2025" and reports on the revenue for the "1st half of 2025" (€23.6 million). It includes detailed unaudited consolidated data comparing H1 2025 to H1 2024, segment breakdowns (Radiology vs. Bone Densitometry), and discusses business momentum and outlook for the second half of the year. This content structure—a comprehensive financial review for a period shorter than a full year (H1)—is characteristic of an Interim/Quarterly Report. Although it is presented as a 'PRESS RELEASE', its substance is a detailed financial report for the half-year period, making 'Interim / Quarterly Report' (IR) the most appropriate classification over a simple 'Earnings Release' (ER) which usually contains only highlights. H1 2025
2025-07-21 English
DMS GROUP, INNOLUX ET INNOCARE ANNONCENT UN ACCORD DE PRINCIPE EN VUE D'UN PARTENARIAT STRATÉGIQUE DANS L'IMAGERIE MÉDICALE
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a strategic partnership and a potential capital investment (up to 10 million euros) via a reserved capital increase. It details the intent to collaborate with InnoLux and InnoCare. Since this document describes a financing activity and capital structure change (reserved capital increase), it falls under the 'Capital/Financing Update' category.
2025-07-07 French
RENFORCEMENT DE LA STRUCTURE DE GOUVERNANCE DE DMS GROUP : NOMINATION DE JULIEN DELPECH EN TANT QU'ADMINISTRATEUR INDÉPENDANT
Governance Information Classification · 99% confidence The document explicitly announces the reinforcement of the Governance structure through the appointment of Julien Delpech as an Independent Director following the General Meeting of June 16, 2025. It also mentions the resignation of another director. This content directly relates to changes in the company's board of directors and senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an AGM presentation (AGM-R), a general governance report (CGR), or a voting result announcement (DVA), but specifically a management/board change announcement.
2025-06-17 French
STRENGTHENING OF DMS GROUP'S GOVERNANCE STRUCTURE: APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR
Governance Information Classification · 99% confidence The document explicitly announces the 'APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR' following the Annual General Meeting (AGM). It details changes in the Board of Directors, including the appointment of a new director and the resignation of another. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. Although an AGM is mentioned, the core subject is the board change, not the AGM materials themselves (AGM-R) or the voting results (DVA).
2025-06-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.